Prim S.A. (PRM) - Net Assets
Based on the latest financial reports, Prim S.A. (PRM) has net assets worth €137.54 Million EUR (≈ $160.79 Million USD) as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€209.04 Million ≈ $244.39 Million USD) and total liabilities (€71.50 Million ≈ $83.59 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check PRM capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €137.54 Million |
| % of Total Assets | 65.79% |
| Annual Growth Rate | 7.05% |
| 5-Year Change | 13.31% |
| 10-Year Change | 36.49% |
| Growth Volatility | 5.01 |
Prim S.A. - Net Assets Trend (2004–2025)
This chart illustrates how Prim S.A.'s net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see market value of Prim S.A..
Annual Net Assets for Prim S.A. (2004–2025)
The table below shows the annual net assets of Prim S.A. from 2004 to 2025. Also explore Prim S.A. (PRM) net asset momentum to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | €137.64 Million ≈ $160.92 Million |
+6.75% |
| 2024-12-31 | €128.93 Million ≈ $150.74 Million |
+2.47% |
| 2023-12-31 | €125.82 Million ≈ $147.10 Million |
+5.11% |
| 2022-12-31 | €119.71 Million ≈ $139.95 Million |
-1.45% |
| 2021-12-31 | €121.47 Million ≈ $142.01 Million |
+8.71% |
| 2020-12-31 | €111.74 Million ≈ $130.64 Million |
+0.62% |
| 2019-12-31 | €111.05 Million ≈ $129.83 Million |
+2.03% |
| 2018-12-31 | €108.84 Million ≈ $127.24 Million |
+2.61% |
| 2017-12-31 | €106.07 Million ≈ $124.00 Million |
+5.18% |
| 2016-12-31 | €100.84 Million ≈ $117.90 Million |
+9.32% |
| 2015-12-31 | €92.25 Million ≈ $107.85 Million |
-0.45% |
| 2014-12-31 | €92.66 Million ≈ $108.33 Million |
+9.33% |
| 2013-12-31 | €84.76 Million ≈ $99.09 Million |
+8.38% |
| 2012-12-31 | €78.20 Million ≈ $91.42 Million |
+8.33% |
| 2011-12-31 | €72.19 Million ≈ $84.39 Million |
+6.98% |
| 2010-12-31 | €67.48 Million ≈ $78.89 Million |
+8.45% |
| 2009-12-31 | €62.22 Million ≈ $72.74 Million |
+14.39% |
| 2008-12-31 | €54.39 Million ≈ $63.59 Million |
+11.23% |
| 2007-12-31 | €48.90 Million ≈ $57.17 Million |
+15.53% |
| 2006-12-31 | €42.32 Million ≈ $49.48 Million |
+17.90% |
| 2005-12-31 | €35.90 Million ≈ $41.97 Million |
+9.14% |
| 2004-12-31 | €32.89 Million ≈ $38.45 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Prim S.A.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 251.6% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €16.68 Million | 12.12% |
| Common Stock | €4.26 Million | 3.09% |
| Other Components | €116.70 Million | 84.79% |
| Total Equity | €137.64 Million | 100.00% |
Prim S.A. Competitors by Market Cap
The table below lists competitors of Prim S.A. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Protara Therapeutics Inc
NASDAQ:TARA
|
$217.47 Million |
|
Iljin Holdings
KO:015860
|
$217.52 Million |
|
Patec Precision Industry Co Ltd
TW:2236
|
$217.63 Million |
|
Yesco Holdings Co. Ltd
KO:015360
|
$217.65 Million |
|
Piedmont Lithium Inc
AU:PLL
|
$217.40 Million |
|
TBI Motion Technology Co Ltd
TW:4540
|
$217.38 Million |
|
Hexagon Purus As
OL:HPUR
|
$217.33 Million |
|
Bank of Zhengzhou Co. Ltd
F:3BZ
|
$217.32 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Prim S.A.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 128,932,000 to 137,641,000, a change of 8,709,000 (6.8%).
- Net income of 16,683,000 contributed positively to equity growth.
- Dividend payments of 7,985,000 reduced retained earnings.
- Share repurchases of 3,293,000 reduced equity.
- New share issuances of 71,328 increased equity.
- Other comprehensive income decreased equity by 114,634,327.
- Other factors increased equity by 117,866,999.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €16.68 Million | +12.12% |
| Dividends Paid | €7.99 Million | -5.8% |
| Share Repurchases | €3.29 Million | -2.39% |
| Share Issuances | €71.33K | +0.05% |
| Other Comprehensive Income | €-114.63 Million | -83.29% |
| Other Changes | €117.87 Million | +85.63% |
| Total Change | €- | 6.75% |
Book Value vs Market Value Analysis
This analysis compares Prim S.A.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 156.35x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 4.15x to 156.35x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2004-12-31 | €3.05 | €12.65 | x |
| 2005-12-31 | €2.77 | €12.65 | x |
| 2006-12-31 | €3.26 | €12.65 | x |
| 2007-12-31 | €3.70 | €12.65 | x |
| 2008-12-31 | €3.54 | €12.65 | x |
| 2009-12-31 | €3.67 | €12.65 | x |
| 2010-12-31 | €3.97 | €12.65 | x |
| 2011-12-31 | €4.25 | €12.65 | x |
| 2012-12-31 | €4.62 | €12.65 | x |
| 2013-12-31 | €4.99 | €12.65 | x |
| 2014-12-31 | €5.42 | €12.65 | x |
| 2015-12-31 | €5.38 | €12.65 | x |
| 2016-12-31 | €6.03 | €12.65 | x |
| 2017-12-31 | €6.12 | €12.65 | x |
| 2018-12-31 | €6.28 | €12.65 | x |
| 2019-12-31 | €6.41 | €12.65 | x |
| 2020-12-31 | €6.45 | €12.65 | x |
| 2021-12-31 | €7.05 | €12.65 | x |
| 2022-12-31 | €7.02 | €12.65 | x |
| 2023-12-31 | €7.40 | €12.65 | x |
| 2024-12-31 | €7.58 | €12.65 | x |
| 2025-12-31 | €0.08 | €12.65 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Prim S.A. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 12.12%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 6.63%
- • Asset Turnover: 1.28x
- • Equity Multiplier: 1.43x
- Recent ROE (12.12%) is below the historical average (12.77%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2004 | 14.42% | 7.36% | 0.98x | 2.01x | €1.45 Million |
| 2005 | 15.91% | 7.94% | 0.92x | 2.18x | €2.12 Million |
| 2006 | 17.85% | 8.34% | 1.10x | 1.95x | €3.32 Million |
| 2007 | 20.57% | 10.98% | 1.07x | 1.75x | €5.17 Million |
| 2008 | 18.21% | 10.34% | 1.02x | 1.73x | €4.47 Million |
| 2009 | 16.13% | 10.51% | 0.96x | 1.61x | €3.81 Million |
| 2010 | 12.64% | 8.97% | 0.86x | 1.64x | €1.78 Million |
| 2011 | 12.34% | 9.74% | 0.78x | 1.63x | €1.69 Million |
| 2012 | 11.68% | 10.30% | 0.85x | 1.34x | €1.31 Million |
| 2013 | 11.37% | 11.07% | 0.80x | 1.28x | €1.16 Million |
| 2014 | 10.75% | 10.57% | 0.81x | 1.26x | €695.54K |
| 2015 | 11.60% | 10.79% | 0.85x | 1.26x | €1.48 Million |
| 2016 | 12.99% | 11.90% | 0.86x | 1.27x | €3.01 Million |
| 2017 | 13.10% | 11.46% | 0.88x | 1.30x | €3.29 Million |
| 2018 | 12.97% | 10.50% | 0.97x | 1.27x | €3.24 Million |
| 2019 | 10.10% | 7.43% | 1.01x | 1.35x | €112.93K |
| 2020 | 6.19% | 4.70% | 0.90x | 1.46x | €-4.26 Million |
| 2021 | 14.34% | 10.34% | 0.94x | 1.48x | €5.28 Million |
| 2022 | 7.01% | 4.25% | 1.07x | 1.55x | €-3.58 Million |
| 2023 | 10.07% | 5.85% | 1.08x | 1.59x | €90.80K |
| 2024 | 8.47% | 4.68% | 1.23x | 1.48x | €-1.97 Million |
| 2025 | 12.12% | 6.63% | 1.28x | 1.43x | €2.92 Million |
Industry Comparison
This section compares Prim S.A.'s net assets metrics with peer companies in the Medical Instruments & Supplies industry.
No peer company data available for comparison.
About Prim S.A.
Prim, S.A. operates as a health technology, mobility, and health care products provider in Spain. The company offers collar, clavicle, armsling, hand and finger, shoulder, elbow, and wrist products. Its lower limbs products include calf brace, thigh, hip, knee, ankle, and foot related products. The company provides shoulder and back supports, bands, corsets, hyperextension braces, and thoracic pr… Read more